Method and device for determining a coronary microvascular resistance score
Summary
USPTO granted Patent US12593988B2 to QFR Solutions B.V. covering methods and devices for determining coronary microvascular resistance scores to assess myocardial tissue perfusion. The patent describes using blood pressure data, flow data, and throughflow geometry data to generate microvascular resistance scores via an electronic output signal for display. Medical device manufacturers developing cardiac diagnostic technologies should review this patent for potential freedom-to-operate implications.
What changed
USPTO granted Patent US12593988B2 to QFR Solutions B.V. on April 7, 2026. The patent covers methods for determining a microvascular resistance score indicating myocardial tissue perfusion, involving acquisition of blood pressure and flow data in a cardiac vessel, generation of adjusted data corresponding to a second physiological state, and output of the resistance score via electronic signal for display.
This is a routine patent grant notice with no compliance obligations or deadlines. Medical device manufacturers and healthcare providers developing or using cardiac diagnostic methods should review this patent when assessing intellectual property positions or developing competing technologies.
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Method and device for determining a coronary microvascular resistance score
Grant US12593988B2 Kind: B2 Apr 07, 2026
Assignee
QFR Solutions B.V.
Inventors
Javier Escaned-Barbosa, Hernán David Mejía Rentería, Johan Hendrikus Christiaan Reiber
Abstract
A method of determining a microvascular resistance score indicating perfusion of myocardial tissue in a body of a mammal is provided, comprising obtaining acquired blood pressure data and flow data of blood in a cardiac vessel while the mammal is in a first physiological state; obtaining throughflow data indicative of a geometry the cardiac vessel; generating adjusted blood pressure data and adjusted flow data corresponding to a second physiological state, based on the acquired blood pressure value and the first physiological state; generating the microvascular resistance score, based on the adjusted blood pressure data, the adjusted flow data and the throughflow data; and providing, through an electronic output signal, the microvascular resistance score for display on an electronic display module.
CPC Classifications
A61B 5/02007 A61B 5/021 A61B 5/026 A61B 5/0044 A61B 5/0215 A61B 5/7278 A61B 5/1076 G16H 30/40 G16H 50/50
Filing Date
2021-07-23
Application No.
18017706
Claims
15
Related changes
Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.